Alkem Laboratories Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
65022.44 Cr.
|
P/BV
|
7.19
|
Book Value (Rs.)
|
756.52
|
52 Week High/Low (Rs.)
|
5520/3186
|
FV/ML
|
2/1
|
P/E(X)
|
66.07
|
Bookclosure
|
17/02/2024
|
EPS (Rs.)
|
82.31
|
Div Yield (%)
|
0.92
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 82.31 | 137.63 | 132.57 | 94.26 | 63.61 |
Diluted EPS (Rs.) | 82.31 | 137.63 | 132.57 | 94.26 | 63.61 |
Cash EPS (Rs.) | 110.18 | 165.98 | 158.29 | 117.28 | 80.87 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 789.21 | 740.05 | 632.20 | 527.73 | 466.08 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 789.21 | 740.05 | 632.20 | 527.73 | 466.08 |
Revenue From Operations / Share (Rs.) | 970.24 | 889.52 | 741.53 | 697.98 | 615.41 |
PBDIT / Share (Rs.) | 152.70 | 185.33 | 181.98 | 131.96 | 100.58 |
PBIT / Share (Rs.) | 126.73 | 159.90 | 159.01 | 110.82 | 84.42 |
PBT / Share (Rs.) | 109.14 | 154.27 | 154.09 | 105.38 | 79.85 |
Net Profit / Share (Rs.) | 84.22 | 140.55 | 135.32 | 96.14 | 64.71 |
NP After MI And SOA / Share (Rs.) | 82.32 | 137.65 | 132.58 | 94.28 | 63.61 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 15.73 | 20.83 | 24.54 | 18.90 | 16.34 |
PBIT Margin (%) | 13.06 | 17.97 | 21.44 | 15.87 | 13.71 |
PBT Margin (%) | 11.24 | 17.34 | 20.77 | 15.09 | 12.97 |
Net Profit Margin (%) | 8.67 | 15.80 | 18.24 | 13.77 | 10.51 |
NP After MI And SOA Margin (%) | 8.48 | 15.47 | 17.87 | 13.50 | 10.33 |
Return on Networth / Equity (%) | 10.88 | 19.05 | 21.48 | 18.29 | 13.98 |
Return on Capital Employeed (%) | 15.07 | 20.63 | 24.01 | 19.77 | 16.84 |
Return On Assets (%) | 7.15 | 11.69 | 13.75 | 11.33 | 9.26 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 |
Total Debt / Equity (X) | 0.14 | 0.29 | 0.22 | 0.25 | 0.16 |
Asset Turnover Ratio (%) | 0.83 | 0.71 | 0.69 | 0.77 | 0.76 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 2.35 | 1.76 | 1.92 | 1.70 | 1.90 |
Quick Ratio (X) | 1.65 | 1.13 | 1.28 | 1.14 | 1.22 |
Inventory Turnover Ratio (X) | 1.09 | 1.33 | 1.23 | 1.39 | 1.23 |
Dividend Payout Ratio (NP) (%) | 53.45 | 0.00 | 21.12 | 31.82 | 23.58 |
Dividend Payout Ratio (CP) (%) | 40.63 | 0.00 | 18.00 | 25.99 | 18.80 |
Earning Retention Ratio (%) | 46.55 | 0.00 | 78.88 | 68.18 | 76.42 |
Cash Earning Retention Ratio (%) | 59.37 | 0.00 | 82.00 | 74.01 | 81.20 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 17.00 | 42.31 | 36.92 | 24.25 | 22.01 |
Interest Coverage Ratio (Post Tax) (%) | 11.34 | 33.37 | 28.46 | 18.67 | 15.16 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 39701.27 | 43453.40 | 33002.69 | 28474.91 | 21316.35 |
EV / Net Operating Revenue (X) | 3.42 | 4.09 | 3.72 | 3.41 | 2.90 |
EV / EBITDA (X) | 21.75 | 19.61 | 15.17 | 18.05 | 17.73 |
MarketCap / Net Operating Revenue (X) | 3.50 | 4.07 | 3.74 | 3.34 | 2.85 |
Retention Ratios (%) | 46.54 | 0.00 | 78.87 | 68.17 | 76.41 |
Price / BV (X) | 4.49 | 5.01 | 4.49 | 4.52 | 3.85 |
Price / Net Operating Revenue (X) | 3.50 | 4.07 | 3.74 | 3.34 | 2.85 |
EarningsYield | 0.02 | 0.03 | 0.04 | 0.04 | 0.03 |